Skip to main content
SpringerLink
Log in

Drug Treatment of Migraine in Children

A Comparative Review

  • Review Article
  • Published:
Pediatric Drugs Aims and scope Submit manuscript

Abstract

Migraine, according to the criteria of the International Headache Society, occurs in about 3 to 7% of all children. Despite this high incidence, and unlike the situation with adult migraine, only a very few controlled trials have investigated the acute and prophylactic treatment of migraine in children.

In the acute migraine attack, ibuprofen 10 mg/kg and paracetamol (acetaminophen) 15 mg/kg have been shown to be effective, with only a few adverse effects. In severe migraine attacks, dihydroergotamine mesylate (dihydroergotamine) administered orally (20 to 40 µg/kg) or intravenously (maximum 1 mg/day) may be helpful, but there have been no large placebo-controlled trials of this treatment. Oral sumatriptan has not been effective in several double-blind and placebo-controlled trials; administered subcutaneously, this drug might be helpful but the only data for this application come from open trials.

For migraine prophylaxis, only flunarizine 5 mg/day has been shown to be effective in more than 1 double-blind, placebo-controlled trial. Some evidence also exists that propranolol >60 mg/day and pizotifen 0.5 to 1.5 mg/day are effective; however, the results from different trials are contradictory. For all other drugs studied in migraine prophylaxis, the results remain vague (e.g. amitriptyline, nimodipine, trazodone) or suggest inefficacy (e.g. timolol, clonidine, tryptophan). In migraine-related disorders, pizotifen 0.5 to 0.75 mg/day for abdominal migraine and flunarizine 10 to 25 mg/day for alternating hemiplegia have been shown to be effective.

Most of the drugs used in the treatment of migraine in children are well tolerated and without relevant adverse effects. In migraine prophylaxis, the most common adverse effects are drowsiness and bodyweight gain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Duckro PN, Cantwell-Simmons E. A review of studies evaluating biofeedback and relaxation training in the management of pediatric headache. Headache 1989; 29: 428–33

    Article  PubMed  CAS  Google Scholar 

  2. Dooley J, Bagnell A. The prognosis and treatment of headaches in children: a ten year follow-up. Can J Neurol Sci 1995; 22: 47–9

    PubMed  CAS  Google Scholar 

  3. Hermann C, Kim M, Blanchard EB. Behavioral and prophylactic pharmacological intervention studies of pediatric migraine: an exploratory meta-analysis. Pain 1995; 60: 239–56

    Article  PubMed  CAS  Google Scholar 

  4. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8 Suppl. 7: 1–96

    Google Scholar 

  5. Rossi LN, Cortinouis I, Bellettini G, et al. Diagnostic criteria for migraine and psychogenic headache in children. Dev Med Child Neurol 1992; 34: 516–23

    Article  PubMed  CAS  Google Scholar 

  6. Hockaday JM, Barlow CF. Headache in children. In: Olesen J, Tfelt-Hansen P, Welch KMA, editors. The headaches. New York: Raven Press, 1993: 795–808

    Google Scholar 

  7. Bille B. Migraine in schoolchildren. Acta Paediatr 1962; 51 Suppl. 136: 1–151

    Google Scholar 

  8. Goldstein M, Chen TC. The epidemiology of disabling headache. Adv Neurol 1982; 33: 377–90

    PubMed  CAS  Google Scholar 

  9. Bille B. Migraine in childhood and its prognosis. Cephalalgia 1981; 1: 71–5

    Article  PubMed  CAS  Google Scholar 

  10. Bruyn GW. The epidemiology of migraine: a personal view. Headache 1983; 23: 127–33

    Article  PubMed  CAS  Google Scholar 

  11. Sillanpää M. Changes in the prevalence of migraine and other headache during the first seven school years. Headache 1983; 23: 15–9

    Article  PubMed  Google Scholar 

  12. Dalsgaard-Nielsen T, Engberg-Pedersen H, Holm HE. Clinical and statistical investigations of the epidemiology of migraine. Dan Med Bull 1970; 17: 138–48

    PubMed  CAS  Google Scholar 

  13. Igarashi M, May WN, Golden GS. Pharmacologic treatment of childhood migraine. J Pediatr 1992; 120: 653–7

    Article  PubMed  CAS  Google Scholar 

  14. Symon DNK. Twelve cases of analgesic headache. Arch Dis Child 1998; 78: 555–6

    Article  PubMed  CAS  Google Scholar 

  15. Linder SL. Treatment of childhood headache with dihydroergotamine mesylate. Headache 1994; 34: 578–80

    Article  PubMed  CAS  Google Scholar 

  16. Hämäläinen ML, Hoppu K, Santavuori PR. Oral dihydroergotamine for therapy-resistant migraine attacks in children. Pediatr Neurol 1997; 16: 114–7

    Article  PubMed  Google Scholar 

  17. Congdon PJ, Forsyth WI. Migraine in childhood: a study of 300 children. Dev Med Child Neurol 1979; 21: 209–16

    Article  Google Scholar 

  18. Hämäläinen ML, Hoppu K, Valkeila E, et al. Ibuprofen or acetaminophen for the acute treatment of migraine in children. Neurology 1997; 48: 103–7

    Article  PubMed  Google Scholar 

  19. Soriani S, Battistella PA, Cernetti R, et al. Acetaminophen versus nimesulide for the treatment of juvenile migraine [abstract]. Cephalalgia 1997; 17: 297

    Article  Google Scholar 

  20. Korsgard AG. The tolerability, safety and efficacy of oral sumatriptan 50mg and 100mg for the acute treatment of migraine in adolescents [abstract]. Cephalalgia 1995; 15 Suppl. 16: 99

    Google Scholar 

  21. Hämäläinen ML, Hoppu K, Santavuori P. Sumatriptan for migraine attacks in children: a randomized placebo-controlled study. Neurology 1997; 48: 1100–3

    Article  PubMed  Google Scholar 

  22. MacDonald JT. Treatment of juvenile migraine with subcutaneous sumatriptan. Headache 1994; 34: 581–2

    Article  PubMed  CAS  Google Scholar 

  23. Linder SL. Subcutaneous sumatriptan in the clinical setting: the first 50 consecutive patients with acute migraine in a pediatric neurology office practice. Headache 1996; 36: 419–22

    Article  PubMed  CAS  Google Scholar 

  24. Bille B, Ludvigsson J, Sanner G. Prophylaxis of migraine in children. Headache 1977; 17: 61–3

    Article  PubMed  CAS  Google Scholar 

  25. Singer HS. Migraine headaches in children. Pediatr Rev 1994; 15: 94–101

    Article  PubMed  CAS  Google Scholar 

  26. Dowson AJ, Fletcher PE, Millson DS. Efficacy and tolerability of ‘Zomig’ in adolescent migraine. Cephalalgia 1998; 18: 406–7

    Google Scholar 

  27. Volans GN. Migraine and drug absorption. Clin Pharmacokinet 1978; 3: 313–8

    Article  PubMed  CAS  Google Scholar 

  28. Massiou H. What is lacking in the treatment of paediatric and adolescent migraine? Cephalalgia 1997; 17 Suppl. 17: 21–4

    PubMed  Google Scholar 

  29. Gatrad AR. Dystonic reactions to metoclopramide. Dev Med Child Neurol 1976; 189: 767–9

    Google Scholar 

  30. Elser JM, Woody RC. Migraine headache in the infant and young children. Headache 1990; 30: 366–8

    Article  Google Scholar 

  31. Sorge F, Barone P, Steardo L, et al. Amitriptyline as a prophylactic for migraine in children. Acta Neurol 1982; 37: 362–7

    Google Scholar 

  32. Sillanpää M. Clonidine prophylaxis of childhood migraine and other vascular headache. Headache 1977; 17: 28–31

    Article  PubMed  Google Scholar 

  33. Sills M, Congdon P, Forsythe I. Clonidine and childhood migraine: a pilot and double-blind study. Dev Med Child Neurol 1982; 24: 837–41

    Article  PubMed  CAS  Google Scholar 

  34. Pothmann R, Winter K. Migraine prophylaxis with DHE: a double blind placebo-controlled study. Cephalalgia 1989; 9 Suppl. 10: 427–8

    Google Scholar 

  35. Caers LI, Ferriere G. Flunarizine in the prophylactic treatment of pediatric migraine [abstract]. J Neurol 1985; 232: 160

    Google Scholar 

  36. Ferriere G. Flunarizine in the prophylactic treatment of paediatric migraine. Cephalalgia 1985; 5 Suppl. 3: 176–7

    Google Scholar 

  37. Guidetti V, Moscate D, Ottaviano S, et al. Flunarizine and migraine in childhood: an evaluation of endocrine function. Cephalalgia 1987; 7: 263–6

    Article  PubMed  CAS  Google Scholar 

  38. Sorge F, Marano E. Flunarizine v. placebo in childhood migraine: a double-blind study. Cephalalgia 1985; 5 Suppl. 2: 145–8

    PubMed  Google Scholar 

  39. Sorge F, de Simone R, Marano E, et al. Flunarizine in prophylaxis of childhood migraine: a double-blind, placebo-controlled, crossover study. Cephalalgia 1988; 8: 1–6

    Article  PubMed  CAS  Google Scholar 

  40. Battistella PA, Ruffilli R, Moro R, et al. A placebo-controlled crossover trial of nimodipine in pediatric migraine. Headache 1990; 30: 264–8

    Article  Google Scholar 

  41. Sillanpää M, Koponen M. Papaverine in the prophylaxis of migraine and other vascular headaches in children. Acta Paediatr Scand 1978; 67: 209–12

    Article  PubMed  Google Scholar 

  42. Gillies D, Sills M, Forsythe I. Pizotifen (Sandomigran) in childhood migraine. Eur Neurol 1986; 25: 32–5

    Article  PubMed  CAS  Google Scholar 

  43. Salmon MA. Pizotifen (BC.105. Sandomigran) in the prophylaxis of childhood migraine [abstract]. Cephalalgia 1985; 5 Suppl. 3: 178

    Google Scholar 

  44. Symon DNK, Russell G. The general paediatricians view of migraine: a review of 250 cases. In: Lanzi G, Balottin U, Cernibori A, editors. Headache in children and adolescents. Amsterdam: Elsevier, 1989: 61–6

    Google Scholar 

  45. Ludvigsson J. Propranolol in treatment of migraine in children [letter]. Lancet 1973; II: 799

    Article  Google Scholar 

  46. Ludvigsson J. Propranolol used in prophylaxis of migraine in children. Acta Neurol Scand 1974; 50: 109–15

    Article  PubMed  CAS  Google Scholar 

  47. Forsythe WI, Gillies D, Sills MA. Propranolol in the treatment of childhood migraine. Dev Med Child Neurol 1984; 26: 737–41

    Article  PubMed  CAS  Google Scholar 

  48. Olness K, McDonald JT, Uden DL. Comparison of self-hypnosis and propranolol in the treatment of juvenile classic migraine. Pediatrics 1987; 79: 593–7

    PubMed  CAS  Google Scholar 

  49. Noronha MJ. Double blind randomised cross-over trial of timolol in migraine prophylaxis of children. Cephalalgia 1985; 5 Suppl. 3: 174–5

    Google Scholar 

  50. Battistella PA, Ruffilli R, Cernetti R, et al. A placebo-controlled crossover trial using trazodone in pediatric migraine. Headache 1993; 33: 36–9

    Article  PubMed  CAS  Google Scholar 

  51. Santucci M, Cortelli P, Rossi PG, et al. L-5-Hydroxtryptophan versus placebo in childhood migraine prophylaxis: a doubleblind crossover study. Cephalalgia 1986; 6: 155–7

    Article  PubMed  CAS  Google Scholar 

  52. Pothmann R. Calcium-antagonist flunarizine vs. low-dose acetylsalicylic acid in childhood migraine: a double blind study. Cephalalgia 1987; 7 Suppl. 6: 385–6

    Google Scholar 

  53. Lavenstein B. A comparative study of cyproheptadine, amitriptyline, and propranolol in the treatment of pre-adolescent migraine. Cephalalgia 1991; 11 Suppl. 11: 122–3

    Google Scholar 

  54. Mastrosimone F, Caterina G, Iaccarino C, et al. The dopaminergic antagonists in childhood headache. In: Lanzi G, Balottin U, Cernibori A, editors. Headache in children and adolescents. Amsterdam: Elsevier, 1989: 233–6

    Google Scholar 

  55. Del Bene E, Poggioni M, Michelacci S. Lisuride as a migraine prophylactic in children: an open clinical trial. Int J Clin Pharmacol Res 1983; 3: 137–41

    PubMed  Google Scholar 

  56. Castellana M, Carini U, Capirci G, et al. Calcium entry blockers in the treatment of primary headache in childhood: our experience with flunarizine and nimodipine. In: Lanzi G, Balottin U, Cernibori A, editors. Headache in children and adolescents. Amsterdam: Elsevier, 1989: 349–52

    Google Scholar 

  57. Lütschg J, Vassella F. Behandlung der kindlichen Migräne mit Flunarizin bzw. Propranolol. Schweiz Med Wochenschr 1990; 120: 1731–6

    Google Scholar 

  58. Burgio R, Borgatti R, Scarabello E, et al. The pharmacological treatment of migraine with tryptophan and pizotifen. In: Lanzi G, Balottin U, Cernibori A, editors. Headache in children and adolescents. Amsterdam: Elsevier, 1989: 339–47

    Google Scholar 

  59. Diamond S, Kudrow L, Stevens J, et al. Long-term study of propranolol in the treatment of migraine. Headache 1982; 22: 268–71

    Article  PubMed  CAS  Google Scholar 

  60. International Headache Society Committee on Clinical Trials. Guidelines for controlled trials of drugs in migraine. Cephalalgia 1991; 11: 1–12

    Article  Google Scholar 

  61. Symon DNK, Russell G. Double blind placebo controlled trial of pizotifen syrup on the treatment of abdominal migraine. Arch Dis Child 1995; 72: 48–50

    Article  PubMed  CAS  Google Scholar 

  62. Hosking GP, Cavanagh NPC, Wilson J. Alternating hemiplegia: complicated migraine of infancy. Arch Dis Child 1978; 53: 656–9

    Article  PubMed  CAS  Google Scholar 

  63. Silver K, Andermann F. Alternating hemiplegia of childhood: a study of 10 patients and results of flunarizine treatment. Neurology 1993; 43: 36–41

    Article  PubMed  CAS  Google Scholar 

  64. Caers LI, de Beukelaar F, Amery WK. Flunarizine, a calcium-entry blocker, in childhood migraine, epilepsy, and alternating hemiplegia. Clin Neuropharmacol 1987; 10: 162–8

    Article  PubMed  CAS  Google Scholar 

  65. Casaer P. Flunarizine in alternating hemiplegia in childhood: an international study in 12 children. Neuropediatrics 1987; 18: 191–5

    Article  PubMed  CAS  Google Scholar 

  66. Cortelli P, Santucci M, Righetti F, et al. Hormonal and metabolic changes induced by flunarizine therapy. Cephalalgia 1985; 5 Suppl. 3: 358–9

    Google Scholar 

  67. McGrath PJ, Humphreys P, Keene D, et al. The efficacy and efficiency of a self-administered treatment for adolescent migraine. Pain 1992; 49: 321–4

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, University of Münster, Albert-Schweitzer-Strasse 33, D-48129, Münster, Germany

    Stefan Evers

Authors
  1. Stefan Evers
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stefan Evers.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Evers, S. Drug Treatment of Migraine in Children. Pediatr-Drugs 1, 7–18 (1999). https://doi.org/10.2165/00128072-199901010-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128072-199901010-00002

Keywords

Search

Navigation